| CABG | Valve | Valve + CABG | TA | TA + CABG | ||||
---|---|---|---|---|---|---|---|---|---|
Total | 73,700 (cases) | 26,597 | 23,136 | 4,726 | 17,441 | 1,800 | |||
DSWI | Incidence | 1.8 (%) | 1.8 | 1.3 | 2.8 | 1.9 | 3.4 | ||
30 day mortality | Total | 9.7 (%) | 5.2 | 10.5 | 10.0 | 14.1 | 17.7 | ||
Re-exploration for bleeding | - | 8.1 (%) | 4.3 | 8.8 | 10.7 | 11.6 | 13.0 | ||
+ | 23.0 (%) | 18.2 | 22.9 | 0 | 26.9 | 31.3 | |||
Operative mortality | Total | 25.8 (%) | 19.0 | 23.0 | 22.3 | 34.9 | 50.0 | ||
Re-exploration for bleeding | - | 22.0 (%) | 17.5 | 20.7 | 22.1 | 30.5 | 43.5 | ||
+ | 48.0 (%) | 39.4 | 40.0 | 25.0 | 57.7 | 68.8 | |||
Duration until death | Re-exploration for bleeding | - | 78.1 (days) | 93.4 | 55.5 | 62.4 | 77.5 | 95.7 | |
+ | 68.2 (days) | 62.1 | 62.2 | 41.5 | 67.2 | 90.0 |